Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 6 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 2 |
| Contract Research Organization Market to 2018 - Introduction | 10 | 1 |
| GBI Research Report Guidance | 10 | 1 |
| Contract Research Organization Market to 2018 - Overview | 11 | 6 |
| Global Contract Research Organizations | 11 | 1 |
| Clinical Research Process | 11 | 1 |
| Drug Discovery Phase | 11 | 1 |
| Pre-Clinical Phase | 11 | 1 |
| Phase I | 11 | 1 |
| Phase II | 11 | 1 |
| Phase III | 11 | 1 |
| Review and Approval from Regulatory Agencies | 12 | 1 |
| Post-marketing Studies | 12 | 1 |
| Key Reasons Outsourcing Clinical Trials and Research Processes | 12 | 1 |
| Different Strategies Adopted by the Pharmaceutical Companies to Increase the Efficiency | 12 | 1 |
| Increase in R&D Costs Compared to Revenue Growth | 13 | 1 |
| Increasing Drug Failure Rates a Concern for Pharmaceutical Companies | 14 | 1 |
| Less Time Required to Launch a Product in the Market | 14 | 1 |
| Outsourcing to Site Management Organizations | 15 | 1 |
| Minimization of Development Risks through Risk Sharing | 16 | 1 |
| Contract Research Organizations can Effectively Manage the Trends in Regulations Governing Clinical Trials | 16 | 1 |
| Contract Research Organization Market to 2018 - Important Trends in Regulatory Aspects of Contract Research Organizations | 17 | 1 |
| New Pharmacovigilance Legislation | 17 | 1 |
| Reasons for Passing the New Legislation | 17 | 1 |
| Important Regulations by Food and Drug Administration in Proposal | 17 | 1 |
| Exculpatory Language to be Used in Informed Consent Forms | 17 | 1 |
| Risk-based Approach to Monitoring Strategies | 17 | 1 |
| Food and Drug Administration Motivating Contract Research Organizations to Use Adaptive Design in Drug Development | 17 | 1 |
| Contract Research Organization Market to 2018 - Technology Developments to Benefit Contract Research Organizations | 18 | 9 |
| Analytics and Intelligence to Meet Contract Research Organizations High Expectations | 18 | 1 |
| Technological Developments in Clinical Research | 18 | 1 |
| Biomarkers | 18 | 1 |
| Nanotechnology | 18 | 1 |
| Genomics, Proteomics and Metabolomics | 19 | 1 |
| Toxicogenomics | 19 | 1 |
| Surgical Models | 19 | 1 |
| Transgenic Animal Models | 20 | 1 |
| Simulation Models | 20 | 1 |
| Information Technology in R&D | 20 | 1 |
| Data Management | 20 | 1 |
| Clinical Data Management System | 21 | 1 |
| Clinical Data Management Outsourcing | 21 | 1 |
| Individual Project Outsourcing Model | 22 | 1 |
| Full Time Equivalent Model | 22 | 1 |
| Functional Service Provider Model | 22 | 1 |
| Deals in Clinical Trial Data Management Outsourcing | 22 | 1 |
| Tata Consultancy Services Eli Lilly | 22 | 1 |
| Cognizant AstraZeneca | 23 | 1 |
| Technology Support Will Be Fundamental to Future of Personalized Medicine | 23 | 1 |
| eClinical Trial Solutions | 24 | 1 |
| Clinical Trial Management System | 24 | 1 |
| Electronic Data Capture | 25 | 1 |
| Using Virtual Technology to Reduce R&D Costs and Time | 26 | 1 |
| Contract Research Organization Market to 2018 - Internal Reorganization | 27 | 5 |
| Restructuring R&D | 27 | 1 |
| GlaxoSmithKline Realigning Focus to Vaccines, Consumer Healthcare and Emerging Markets | 28 | 1 |
| Pfizer Redefining the Research Focus and Outsourcing the Rest | 29 | 1 |
| AstraZeneca Consolidating R&D Facilities with Narrowed Therapeutic Focus | 30 | 1 |
| Sanofi Combining Workforce Consolidation with Externalization to Safeguard Future Revenue | 31 | 1 |
| Contract Research Organization Market to 2018 - Public-Private Partnerships | 32 | 10 |
| Public-Private Partnerships | 32 | 1 |
| Public-Private Partnerships for R&D in the Pharmaceutical Industry | 32 | 1 |
| Private-Government Partnerships | 32 | 1 |
| Innovative Medicine Initiative in Europe | 32 | 2 |
| Cooperative Research and Development Agreements in the US | 34 | 1 |
| Cooperative Research and Development Agreement for Pharmaceutical R&D | 35 | 1 |
| Advaxis Signs Cooperative Research and Development Agreement with Vaccine Branch of National Cancer Institute | 35 | 1 |
| Oxygen Biotherapeutics Signs Cooperative Research and Development Agreement with the US Neval Medical Research Center | 35 | 1 |
| Adamas Signs Cooperative Research and Development Agreement with the US Naval Health Research Center | 35 | 1 |
| Proximagen Group Signs Cooperative Research and Development Agreement with National Institute of Neurological Disorders and Stroke for Naluzotan Development | 35 | 1 |
| Small Business Innovation Research Program | 36 | 1 |
| Case Study One: Optivia Received Grants from the National Institute of Health | 36 | 1 |
| Case Study Two: Avexia Biologics Received Grants from National Institute of Health | 37 | 1 |
| Case Study Three: MBC Pharma Awarded Grant by National Institute of Health | 37 | 1 |
| Public-Private Partnership in India | 37 | 1 |
| Blockbusters from the US Funding | 37 | 1 |
| Technology Transfer Issues | 37 | 1 |
| Technology Transfer between Federal Agencies and Private Organizations | 37 | 1 |
| Technology Transfer between Academic Institutions and the Pharmaceutical Industry | 37 | 1 |
| Technology Transfer in Licensing | 37 | 1 |
| Technology Transfer to Emerging Economies | 38 | 1 |
| Case Study One: FluMist Technology Transfer National Institute of Allergy and Infectious Diseases to Aviron | 38 | 1 |
| Case Study Two: Collaboration between Firocuz and GlaxoSmithKline | 39 | 1 |
| Laws Enabling Technology Transfer in the US | 40 | 1 |
| Bayh-Dole Act | 40 | 1 |
| Stevenson-Wydler Technology Innovation Act | 40 | 1 |
| Open-source R&D | 40 | 1 |
| Crowdsourcing | 40 | 1 |
| Applicability of Crowdsourcing to the Pharmaceutical Industry | 41 | 1 |
| Sage Bionetworks Receives Funding from Quintiles | 41 | 1 |
| Eli Lilly Announces Phenotypic Drug Discovery Initiative | 41 | 1 |
| Contract Research Organization Market to 2018 - Market Characterization | 42 | 6 |
| Global Clinical Trial Market | 42 | 1 |
| Global Pharmaceutical R&D Outsourcing Market | 43 | 1 |
| Global Contract Research Organization Market by Geography | 44 | 1 |
| Trend Analysis of Contract Research Organization Market by Geography | 45 | 1 |
| Global Contract Research Organization Market by Phase | 46 | 1 |
| Trend Analysis of Contract Research Organization Market by Phase | 47 | 1 |
| Contract Research Organization Market to 2018 - Geographical Landscape | 48 | 26 |
| Emerging Regions in the Global Contract Research Organization Market: Argentina | 48 | 1 |
| Domestic Contract Research Organization Profiles | 49 | 1 |
| Abel Santos &Asociados | 49 | 1 |
| Business Description | 49 | 1 |
| Activa CRO | 50 | 1 |
| Business Description | 50 | 1 |
| Blanchard &Asociados | 51 | 1 |
| Business Description | 51 | 1 |
| EGCP | 52 | 1 |
| Klixar | 53 | 1 |
| Business Description | 53 | 1 |
| LatinClin | 54 | 1 |
| Business Description | 54 | 1 |
| Mmatiss | 55 | 1 |
| Business Description | 55 | 1 |
| Estudios Cl nicos Latinoam rica | 56 | 1 |
| Business Description | 56 | 1 |
| Emerging Regions in the Global Contract Research Organization Market: India | 57 | 1 |
| Domestic Contract Research Organization Profiles | 58 | 1 |
| Reliance Life Sciences | 58 | 1 |
| Business Description | 58 | 1 |
| Asian Clinical Trials | 59 | 1 |
| Business Description | 59 | 1 |
| DiagnoSearch Life Sciences | 60 | 1 |
| Business Description | 60 | 1 |
| ClinInvent | 61 | 1 |
| Synchron Research Services Pvt Ltd | 62 | 1 |
| Business Description | 62 | 1 |
| Lambda Therapeutic Research Ltd | 63 | 1 |
| Business Description | 63 | 1 |
| GVK Biosciences Pvt Ltd | 64 | 1 |
| Business Description | 64 | 1 |
| Veeda Clinical Research Ltd | 65 | 1 |
| Business Description | 65 | 1 |
| Ecron Acunova | 66 | 1 |
| Business Description | 66 | 1 |
| Siro Clinpharm Pvt Ltd | 67 | 1 |
| Business Description | 67 | 1 |
| Emerging Regions in the Global Contract Research Organization Market: China | 68 | 1 |
| Domestic Contract Research Organizations | 69 | 1 |
| Boji Medicine Services Co. Ltd | 69 | 1 |
| Business Description | 69 | 1 |
| Giant Med-Pharma Services Inc | 70 | 1 |
| Business Description | 70 | 1 |
| InCrom | 71 | 1 |
| Business Description | 71 | 1 |
| Pharmaron | 72 | 1 |
| Business Description | 72 | 1 |
| Venturepharm Service Group | 73 | 1 |
| Business Description | 73 | 1 |
| Contract Research Organization Market to 2018 - Competitive Landscape | 74 | 19 |
| Overview | 74 | 1 |
| Market Share Analysis | 75 | 2 |
| Quintiles Transnational Corp | 77 | 1 |
| Business Description | 77 | 1 |
| Recent M&A Deals and Strategic Alliances | 78 | 2 |
| Covance Inc | 80 | 1 |
| Business Description | 80 | 1 |
| Recent M&A Deals and Alliances | 81 | 1 |
| Pharmaceutical Product Development Inc | 82 | 1 |
| Business Description | 82 | 1 |
| Recent M&A Deals and Alliances | 83 | 3 |
| Charles River Laboratories International, Inc | 86 | 1 |
| Business Description | 87 | 1 |
| Recent M&A Deals and Alliances | 88 | 2 |
| Parexel International | 90 | 1 |
| Business Description | 90 | 1 |
| Recent M&A Deals and Alliances | 91 | 2 |
| Contract Research Organization Market to 2018 - Appendix | 93 | 6 |
| Market Definitions | 93 | 1 |
| Abbreviations | 93 | 2 |
| Note | 95 | 1 |
| Research Methodology | 95 | 3 |
| Coverage | 95 | 1 |
| Secondary Research | 95 | 1 |
| Primary Research | 96 | 1 |
| Expert Panel Validation | 96 | 1 |
| Section-wise Research Methodology | 96 | 1 |
| Clinical Trials Overview | 96 | 1 |
| Technology Developments Benefiting Contract Research Organizations | 96 | 1 |
| Public-Private Partnerships | 97 | 1 |
| Market Environment Characterization | 97 | 1 |
| Contract Research Organization Landscape | 97 | 1 |
| Contact Us | 97 | 1 |
| Disclaimer | 98 | 1 |
| Sources | 98 | 1 |